These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15062750)

  • 1. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
    Szpirt W; Somnier F; Nielsen FC; Rødgaard A
    Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoadsorption--a new treatment of myasthenia gravis].
    Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
    Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
    Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
    Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
    Sun C; Meng F; Li Y; Jin Q; Li H; Li F
    Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):99-102. PubMed ID: 20196680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, stability, and effectiveness of immunoadsorption under membrane plasmapheresis treatment for myasthenia gravis.
    Hosokawa S; Oyamaguchi A
    ASAIO Trans; 1990; 36(3):M207-8. PubMed ID: 2252658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
    Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
    Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of myasthenia gravis by immunoadsorption of plasma.
    Grob D; Simpson D; Mitsumoto H; Hoch B; Mokhtarian F; Bender A; Greenberg M; Koo A; Nakayama S
    Neurology; 1995 Feb; 45(2):338-44. PubMed ID: 7854536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
    Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
    J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
    Yeh JH; Chiu HC
    J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
    Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.
    Lefvert AK
    Clin Exp Immunol; 1978 Oct; 34(1):111-7. PubMed ID: 750115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
    Somnier FE; Langvad E
    J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The 2-phase action on mice of immunoglobulins isolated from the blood of a myasthenia patient].
    Smirnov VA; Saĭkova LA; Lobzin VS
    Biull Eksp Biol Med; 1988 Nov; 106(11):549-52. PubMed ID: 3196852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
    Lefvert AK
    Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis.
    Takamori M; Ide Y
    Transfus Sci; 1996 Sep; 17(3):445-53. PubMed ID: 10163553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.